Home › Funds › JPMorgan Chase & Co › CLOV
JPMorgan Chase & Co position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q2 2026)296.37K sh
Reported value held$1.67M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 136.06K | $1.00M | New |
| Q4 2021 | 70.52K | $262.00K | Reduce |
| Q1 2022 | 77.72K | $276.00K | Add |
| Q2 2022 | 322.76K | $691.00K | Add |
| Q3 2022 | 334.64K | $569.00K | Add |
| Q4 2022 | 369.87K | $344 | Add |
| Q1 2023 | 7.31K | $140.00K | Reduce |
| Q2 2023 | 1.72K | $1.54K | Reduce |
| Q3 2023 | 1.72K | $1.86K | Hold |
| Q4 2023 | 127.12K | $121.03K | Add |
| Q1 2024 | 868.54K | $689.62K | Add |
| Q3 2024 | 158.92K | $448.15K | New |
| Q4 2024 | 432.27K | $1.36M | Add |
| Q1 2025 | 447.65K | $1.61M | Add |
| Q1 2025 | 447.65K | $1.61M | Add |
| Q2 2025 | 633.70K | $1.77M | Add |
| Q2 2025 | 633.70K | $1.77M | Add |
| Q3 2025 | 315.25K | $964.65K | Reduce |
| Q4 2025 | 311.49K | $732.01K | Reduce |
| Q2 2026 | 296.37K | $1.67M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Marshall Wace 1.56M sh · $8.19M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026
- BNY Mellon 1.21M sh · $6.35M · Q2 2026